Evidence map›Paper›PMID 20123718›Full record

ArticleInfection and immunity2010

Acute immune response to Mycobacterium massiliense in C57BL/6 and BALB/c mice.

Eduardo Martins de Sousa, Fernando Bonfim de Bortoli, Eduardo Pinheiro Amaral, Aline Carvalho Batista, Thereza Liberman Kipnis, Alessandra Marques Cardoso, André Kipnis, Ana Paula Junqueira-Kipnis

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Deferoxamine Exhibits Antimicrobial and Immunomodulatory Activity AgainstInternational journal of molecular sciences · 2026
    Article
  2. Microorganisms · 2025
    Review
  3. Milk andAmerican journal of physiology. Gastrointestinal and liver physiology · 2024
    Article
  4. TheIndian journal of microbiology · 2019
    Article
  5. Hydroalcoholic Extract and Ethyl Acetate Fraction ofEvidence-based complementary and alternative medicine : eCAM · 2018
    Article
  6. Frontiers in microbiology · 2018
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Eduardo Martins de SousaDepartamento de Microbiologia, Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia-Go, Brazil.
Fernando Bonfim de Bortoli
Eduardo Pinheiro Amaral
Aline Carvalho Batista
Thereza Liberman Kipnis
Alessandra Marques Cardoso
André Kipnis
Ana Paula Junqueira-Kipnis
Universidade Federal de Goiás · BRState University of Norte Fluminense · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacterium massiliense is an environmental opportunistic pathogen that has been associated with soft tissue infection after minor surgery. We studied the acute immune response of C57BL/6 and BALB/c mice infected intravenously with 10(6) CFU of an M. massiliense strain isolated from a nosocomial infection in Brazil. The results presented here show that M. massiliense is virulent and pathogenic to both C57BL/6 and BALB/c mice, inducing a granulomatous inflammatory reaction that involves the activation of macrophages, dendritic cells, and natural killer cells induced by gamma interferon and interleukin-17 (IL-17) in C57BL/6 mice and by IL-12 in BALB/c mice.

Indexed as

AnimalsBacteremiaBrazilCross InfectionDendritic CellsDisease Models, AnimalFemaleGranulomaHumansInterferon-gammaInterleukin-17Killer Cells, NaturalLiverLungMacrophagesMiceInterferon-gammaInterleukin-17

Identifiers

PMID20123718
PMCPMC2849394
OpenAlexW2134636807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.